It is important to obtain structure-activity relationship (SAR) data across cationic lipids for the self-assembly and non-viral intracellular delivery of siRNA. The aims of this work are to carry out a SAR study on the efficiency of asymmetrical N -oleoyl-1,12-diamino-4,9-diazadodecane (LinOS) which is also shown to be comparable with or superior to TransIT-TKO and Lipofectamine 2000.
INTRODUCTION
RNA interference (RNAi) was first noticed in petunia flowers which showed reduced pigmentation on the introduction of exogenous genes that were meant to increase pigmentation. 1, 2 Fire, Mello, and co-workers reported the reduction or inhibition of gene expression of a specific gene in Caenorhabditis elegans by means of dsRNA homologous to the targeted gene. 3 In 2001, gene silencing in mammalian cells mediated by 21 nucleotide dsRNA homologous in sequence to the target gene was reported. 4 Post-transcriptional gene silencing by short or small dsRNA, short interfering RNA (siRNA), typically 21-25 nucleotides in length, is mediated through the RNAinduced silencing complex (RISC) in the cytoplasm. The RISC is comprised of proteins and the anti-sense strand of the siRNA. The key protein that has endoribonuclease activity is one of the Argonaute family of evolutionarily-conserved proteins (e.g. human Argonaute hAgo2) 5 that are essential for development and differentiation, and in most plants and animals defend cells against viral infection. Sequence specific gene silencing is by degradation of mRNA that has a complementary sequence to the anti-sense siRNA strand present in the RISC complex. 5, 6 siRNA continues to gain popularity in functional genomics studies and as a potential therapeutic that can target many diseases ranging from age-related macular degeneration to different types of cancer and viral infections. [7] [8] [9] Due to the highly negatively charged nature of the siRNA phosphate backbone, and due to its susceptibility to degradation by exo-and endo nucleases, 10 a carrier (vector) is required to ensure successful intracellular siRNA delivery to target cells. 11, 12 Since being introduced as non-viral gene delivery vectors in 1987 by Felgner and co-workers, 13 cationic lipids have been widely studied as non-viral gene and siRNA vectors.
14- 16 The majority of phospholipids in mammalian cell membranes are acylated with two different fatty acids at the sn-1 and sn-2 positions of the glycerol 3-phosphate. [17] [18] [19] [20] [21] We have designed and synthesized various diacyl derivatives of spermine, a naturally occurring polyamine. These diacyl substituents, using either the same or two different fatty acids acylated to either positions N 4 and N
9
, or N 1 and N
12
, of spermine were then characterized and evaluated in vitro as non-viral vectors for the delivery of plasmid DNA (pDNA) and scrambled fluorescently labeled siRNA. [22] [23] [24] [25] [26] In this work, we report the design and synthesis of seven new N 4 ,N 9 diacylated asymmetrical spermine derivatives, asymmetrical in that they contain two different fatty acid chains, varying in length (from C18 to C24) and/or in their oxidation state. These novel asymmetrical polyamine amides are structurally similar to the naturally occurring diacyl lipids that form lipid cellular membranes. [17] [18] [19] [20] [21] Using the two positive charges from the terminal primary amino groups, they are rationally designed to neutralize polynucleotides (e.g. siRNA) by titration and without any pre-formulation of liposomes. This titration occurs by the simple mixing of cationic lipids with polyanionic cargoes enabling self-assembly of lipoplex nanoparticles. 22 The target molecules are also designed to be efficient in coating the siRNA cargo with a protective lipid against serum RNase and therefore to be efficient in siRNA mediated gene silencing. We have reported the use in siRNA delivery of long and very long chains symmetrically substituted on spermine, 23 but prior to our studies, there are no structure-activity relationship (SAR) data on asymmetrical spermine conjugates in gene silencing. 27 The synthesized spermine conjugates were homogeneous and characterized by NMR, high-resolution mass spectrometry (HRMS), and DLS. Their -potentials were also measured.
They were then evaluated as non-viral siRNA delivery vectors and compared with commercially available siRNA delivery systems. To this end, we made use of a HeLa cell line that stably expresses the enhanced green fluorescent protein (EGFP) as a target for gene silencing and measured the efficiency of siRNA delivery and the associated reduction of EGFP expression. In the same system, we also investigated the difference between transfection with lipoplexes of the asymmetrical spermine conjugates (e.g. According to the General Procedure, arachidonic acid (304 mg, 1 mmol) was reacted to afford the title compound (301 mg, 40% over two steps). According to the General Procedure, eicosenoic acid (310 mg, 1 mmol) was reacted to afford the title compound (273 mg, 36% over two steps). According to the General Procedure, erucic acid (339 mg, 1 mmol) was reacted to afford the title compound (268 mg, 34% over two steps). According to the General Procedure, lignoceric acid (369 mg, 1 mmol) was reacted to afford the title compound (310 mg, 38% over two steps). According to the General Procedure, nervonic acid (367 mg, 1 mmol) was reacted to afford the title compound (302 mg, 37% over two steps). C18 fatty acids with one or two unsaturation sites resulted in better reduction in EGFP expression. Thus, LinOS (3 g/well) gave 24% EGFP expression, DOS (6 g/well) gave 27% EGFP, compared to OSS (with one stearoyl 18:0) which at 3g/well gave 38% EGFP and at 6 g/well gave 38% EGFP. The quantitative FACS data (Figures 2 and 3) are better illustrated by the flow cytometric graphs comprised of individual histograms (Figure 4 ).
The N/P ratio is defined as the ratio of cationic lipid ammonium ions to RNA phosphate anions. In this case, the numerator is calculated as the number of moles of cationic lipid multiplied by the positive charge carried, 2.0. The value 2.0 reflects the pKa of each primary amine (~10.5) and the pH at which the experiments are performed (7.4) using the HendersonHasselbalch equation. 33 The denominator is the total number of phosphate anions which here is calculated from the total number of moles of siRNA multiplied by the total number of phosphates in ds siRNA, where a synthetic 24-mer carries 23 phosphates in each strand following phosphoramidite synthesis. Though the terminal sugars of uncomplexed siRNA will be phosphorylated in cells, lipoplexes of siRNA are prepared before this reaction, at N/P = 23.8 with DOS (6 g/well), N/P = 21.3 with LigOS (6 g/well), and N/P = 11.9 with LinOS (3g/well) for a fixed amount of siRNA (15 pmol).
Increasing the number of unsaturation sites in C20 fatty acids resulted in better reduction in EGFP expression (down to 37% and 29% at 6 g/well, p < 0.0001; 52% and 34% at 3 g/well; p < 0.0001 for EicOS and AOS respectively). There was no significant statistical difference (p > 0.05) between LigOS and NOS with respect to their effects on EGFP expression. Increasing the chain length of the fatty acid spermine derivatives from C18 to C24 while keeping number of C=C double bonds constant generally resulted in higher levels of EGFP across the series of compounds, with EGFP expression reduced to 26%, 38%, 51%, and 54% at 6 g/well of DOS, EicOS, EruOS, and NOS respectively. There were no differences between EicOS and EruOS at 0.75, 1.5, and 3 g/well. Increasing the chain length from C18 to C24 in OSS and LigOS respectively resulted in higher levels of EGFP expression at different concentrations of lipids. At The EGFP expression and siNC-AF delivery are shown in Figure 5 . The amounts of lipids used were those which resulted in the best reduction in EGFP expression with respect to each cationic lipid (see Figure 3) . The data show that while the delivery of siNC-AF for each cationic lipid, at the specified concentration, was with comparable efficiency to the delivery results of siEGFP-AF (see Figure 2) , there was no significant effect (a maximum of 10% reduction) on EGFP expression percentage. Thus, the reduction in EGFP expression after transfection with siEGFP-AF lipoplexes is mainly due to sequence-specific EGFP knock-down mediated by the delivered siEGFP-AF, and not due to any cationic lipid-related effects, e.g. toxicity. (14) and DEruS (82). 32 There was no statistical significant difference between DOS/DEruS 1:1and EruOS (33 and 31 respectively, p = 0.64). The mixtures mostly behave in a way which reflects the behavior of the individual components ( Figure 6 ). DLinS shows the lowest uptake, consistent with our results (Figure 2) where lipids containing more C=C show lower uptake. DEruS has the highest uptake, also consistent with the results in Figure 2 where the longer and more saturated lipid chains, EruOS, LigOS, and NOS show higher uptake.
However, these mixtures of cationic lipids displayed no synergy in siEGFP-AF delivery as found with DNA transfection. Figure 8b shows that while siEGFP-AF (red) has been delivered, EGFP is still strongly expressed throughout the cell. In Figure 8d , the green channel was turned-off to better visualize the red colour representing siEGFP-conjugated dye AF647
(siEGFP-AF). Note that the lower cell shows higher uptake compared to the upper cell. In Figure   8c , EGFP (green) is barely detectable at 48 h post-transfection, compared to the control untransfected cells shown in Figure 8a . Scattered red dots indicate that siEGFP-AF is still present 48 h post-transfection. Taken together, the photomicrographs shown in Figure 8 demonstrate the apparent efficient uptake of lipoplexes of siEGFP-AF and LinOS (3 µg/well) and the subsequent very dramatic reduction (knock-down) of EGFP expression, at least up to 48 h post-transfection.
We note that LinOS (at 3 and even at 6 µg/well, Figure 2) shows the lowest siRNA delivery, but with siEGFP-AF held constant at 15 pmol/well (15 nM), LinOS (3 µg/well) forms the most efficient lipoplexes for gene silencing (Figure 3 ) even though this high efficacy is not reflected in high delivery. 
36
DLS was used to measure the particle sizes (Table 1 ) of the lipoplexes prepared at the cationic lipid/siRNA ratio that resulted in the largest reduction in EGFP expression. The size range is 145-292 nm (from OSS to AOS) which is in agreement with the size range of lipoplexes previously reported to transfect successfully in cell culture. 37 The particle size could determine the main route of cellular entry, with lipoplexes <300 nm likely to enter via clathrin-mediated endocytosis, and lipoplexes >500 nm entering cells via caveoli-mediated endocytosis. 37, 38 However, the entry route for functional siRNA delivery might be by fusion with the cell membrane rather than via an endocytic pathway, as demonstrated using selective inhibitors. 34 The ζ-potentials of the prepared lipoplexes (Table 1) For pragmatic cell viability assays, we downscaled from the transfection conditions in 24-well (1 mL) format to 96-well (0.1 mL) format, after establishing that 4,000-6,500 cells/well was an optimal range for reproducible results and in order to avoid problems of overconfluency.
To keep the ratios and concentrations the same, the weight of cationic lipid and the amount of siRNA were each reduced to one tenth of their original values. The two cell viability assay conditions we employed reflect the experimental conditions used in gene silencing (0.5 h between seeding and transfection) and in confocal microscopy where the time after seeding was 24 h to allow the cells to attach well and distribute evenly on the cover slips. In comparison, when using FACS to quantify gene silencing, there was no requirement for a long time between seeding and transfection as there was no requirement for stronger attachment to cover slips.
The weight of lipid chosen in Figure 10 is based on the ratio of lipid/siEGFP-AF that resulted in the best reduction in EGFP expression as seen in Figure 3 . Figure 3 ) were reduced from 96% to 84% to 65% to 52% (LinOS) and from 95% to 77% to 50% to 33% (DOS) at 0.075, 0.15, 0.3, and 0.6 g/well respectively. The lowest cell viabilities were due to transfection with EruOS lipoplexes (from 94%, 53%, 26%, and 14% at 0.075, 0.15, 0.3, and 0.6 g/well of EruOS respectively). and also that lipid chain asymmetry has a strong impact on DNA transfection efficiency while keeping the HLB of cationic lipids constant. 39 The human cervical epithelial adenocarcinoma HeLa cell line is a well-described model of cancer cells and hence is a relevant tool for studies on siRNA-or shRNA-mediated silencing.
DISCUSSION
In this paper, as a first step towards assessing the efficiency of our compounds at delivering siRNA into cells, we chose HeLa cells stably expressing a reporter gene coding for the fluorescent protein EGFP, under the control of a constitutive promoter, a strategy used in a number of other studies. 28, 29, 40, 41 The advantages of using a stably transfected cell line are that this simple experimental system allows expression of the protein, translated from the reporter gene at a steady-state level, and a fast assessment on the effect of EGFP-directed siRNA delivery by flow cytometry (FACS) and fluorescence microscopy. Stable transfection of the target gene of interest (with expression vector pEGFP-C1 pDNA in this study) only requires the cells to be kept under selective pressure with an antibiotic (aminoglycoside G418 in our system) to prevent loss of pDNA during cell cultivation. The loss of genome-integrated exogenous pDNA with cell division during in vitro cultivation is a known phenomenon and it can only be reduced/prevented by keeping the cells under some pressure, with a non-toxic antibiotic (G418) concentration.
Furthermore, as in our experimental system cell populations studied are asynchronous, any potential effects of the cell cycle on the reporter gene are averaged and the related protein levels will vary with the efficiency in silencing of the delivered siRNA.
Whilst these studies are in HeLa cells stably expressing EGFP to test the efficiency of the lipoplexes of asymmetrical lipopolyamines to deliver siRNA and then achieve gene silencing, they are comparable with recently reported siRNA delivery in C6 glioma cells stably expressing GFP, 40 and antisense studies in human cervical cancer HeLa705 cells containing an aberrant luciferase gene. 41 Likewise, this in vitro evaluation strategy has been used in HeLa-EGFP cells 28 and HeLa expressing either EGFP or luciferase. 29 It is likely that any correlation with in vivo performance will follow results obtained at high serum levels. 42 siRNA for intravenous administration must be stable in full (human) serum. Our use of 10% FCS is a step towards this.
Non-viral DNA vectors prepared from cationic lipids that are composed of asymmetrical fatty acid chains have been reported to have higher in vitro 43 and/or in vivo 44 proposed that asymmetrical lipids have increased fusogenicity. 45 The effect on DNA transfection efficiency of changing the saturation state in one chain was reported by Koynova et al. 46 Comparing two asymmetric cationic phospholipid derivatives, 
